Consumer demand for natural beauty and skincare products expanded wildly over recent years, prompting an influx of “clean” or “natural” products on store shelves. And this isn’t a passing trend: Statista expects the US natural and organic cosmetics market to grow by $410 million, reaching $1.73 billion USD by 2023. That’s almost a half billion dollars in 3 years, and just in the US.
And according to Grandview Research, the global natural skin care products market size was valued at USD 10.84 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 5.0% from 2020 to 2027.
Cannabinoids have also risen to prominence in cosmetic and skincare products with cannabidiol, CBD, being the most popular ingredient. These ingredients are found in nature, making them right on target for what consumers want. However, in many cases, more research needs to be done to fully demonstrate their efficacy and safety for health and wellness.
Cannabigerol (CBG) is poised to be the next star cannabinoid. Recent research has begun to highlight its possibilities as an antioxidant, anti-microbial and anti-inflammatory. While not as well studied as CBD, the initial data appears promising.
Why CBG?
There are over 100 cannabinoids in the plant, most of which are rare and, until now, have been in too small amounts to isolate them for proper study. Companies like Demetrix, a biotechnology company that believes in the power of science to make the world a better place, have been using modern technology to produce even the rarest cannabinoid as easily as the most abundant.
To access the full article, please supply your email address in the box above.
And according to Grandview Research, the global natural skin care products market size was valued at USD 10.84 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 5.0% from 2020 to 2027.
Cannabinoids have also risen to prominence in cosmetic and skincare products with cannabidiol, CBD, being the most popular ingredient. These ingredients are found in nature, making them right on target for what consumers want. However, in many cases, more research needs to be done to fully demonstrate their efficacy and safety for health and wellness.
Cannabigerol (CBG) is poised to be the next star cannabinoid. Recent research has begun to highlight its possibilities as an antioxidant, anti-microbial and anti-inflammatory. While not as well studied as CBD, the initial data appears promising.
Why CBG?
There are over 100 cannabinoids in the plant, most of which are rare and, until now, have been in too small amounts to isolate them for proper study. Companies like Demetrix, a biotechnology company that believes in the power of science to make the world a better place, have been using modern technology to produce even the rarest cannabinoid as easily as the most abundant.
To access the full article, please supply your email address in the box above.